Emkay Global Financial Recommends Buying Star Health, Sets Rs 700 Target
Emkay Global Financial cited Star Health’s second-quarter claims ratio improving year over year to 69%, versus its 69.8% estimate.
Related stories
BofA Securities Downgrades Intel to Neutral, Cuts Target to $100
BofA Securities lowered its Intel price target from $145 to $100. The new target implies 8.6% upside from the Oct. 29 close of $92.07.
M impact | EQUITY | Oct 30, 2026, 09:22 AM UTC
China Railway Rolling Stock Corp. Q3 Revenue Falls 1.7% YoY
China Railway Rolling Stock Corp. said third-quarter revenue fell 1.7% year over year.
M impact | EQUITY | Oct 30, 2026, 09:13 AM UTC
Corey Fox Launches AEO Services for Shopify Brands
Shopify SEO consultant Corey Fox has launched AEO services for Shopify brands.
M impact | EQUITY | Oct 30, 2026, 09:12 AM UTC
Jakarta Stocks Fall 16.7% in October, Worst Since March 2020
M impact | EQUITY | Oct 30, 2026, 09:05 AM UTC
Erste Bank Polska Reports Third-Quarter Profit in Line With Expectations
Growing mortgage lending and resilient net interest income helped offset Poland’s bank tax hike, the bank said.
M impact | EQUITY | Oct 30, 2026, 09:04 AM UTC
European session market picture: S&P 500 -0.84%, Nasdaq 100 -1.95%; EUR/USD +0.15%, WTI +1.61%, LLOY leads volume
European session market picture. US index futures: S and P futures is down 0.84 percent, Nasdaq futures is down 1.95 percent, Dow futures is up 0.18 percent and Russell futures is
M impact | EQUITY | Oct 30, 2026, 09:01 AM UTC